PMA Perspective Q3 2021

PMA Perspectives Q3 2021


Insights from pharmaceuticals, market access and Team Remap 

The summer came and went and now the nights are drawing in and we’re starting to look forward to Christmas!

With that in mind, welcome to our third edition of Remap Perspectives, where we’ll share the latest #TeamRemap news and a summary of our key blogs and articles from the past three months.

We hope you enjoy and if you have any thoughts on any of the articles or content shared today, please reach out.



Always on the lookout for ambitious and enthusiastic individuals, we’re currently recruiting for various positions including Analyst and Business Development Director.

Fancy a new challenge? Click on the links above for further information on these new exciting roles.


Lauren Boland

We’d like to introduce to you our new Market Access Analyst, Lauren.

Having recently completed her Ph.D, she brings a wealth of scientific knowledge to Remap.

With previous experience in market access consultancy and client facing roles, Lauren will be a tremendous asset to our growing team.


Our Founder and Managing Director Paul Craddy ran the London marathon last weekend, in aid of the fantastic charity RAFT, which helps people rebuild their lives after trauma. Paul set a goal to raise £2,000 for this fantastic charity.

We are extremely proud of his achievement and want to take this opportunity to say a huge thanks to all who have donated so far, however, there is still time to donate to this fantastic charity if you’d like to!

A few words from Paul Craddy “Thanks to all those who have given, it means a huge amount to me. The race itself was amazing and the atmosphere incredible. Such great support. The last few kms were tough but I’m overjoyed to have completed it in 3.57, which is a personal best for me. What a fantastic day!”


We will be presenting at this years’ ISPOR Europe Virtual Event on 1st – 3rd December.

The conference theme for this years’ event is “Emerging Frontiers and Opportunities: Special Populations and Technologies.”

We’re pleased to announce that we have had all three abstracts accepted and look forward to presenting these as posters.

If you would like to connect during the event, please get in touch with Paul or Graham and we’ll schedule some time with you.


 UK Announces £340m fund for new innovative medicines

 Prepare for NICE’s highly specialised technologies process

 What will be the blockbuster drugs in the next decade?

 Real world evidence explained

 Pharmaceutical tendering basics

 Patented medicines: how to navigate loss of exclusivity

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.